1. The essential consequences of polymorphism in the pharmaceutical field
Previous articles and have already given a glimpse of the main consequences expected in the pharmaceutical sector.
They mainly concern :
dissolution kinetics and, possibly, bioavailability;
the manufacturability of the active ingredient and the finished product;
the stability of the latter two.
These areas have already been more or less developed, so we'll confine ourselves here to briefly touching on certain aspects.
1.1 Polymorphism / dissolution kinetics and bioavailability
Most drugs are still prescribed orally (tablets, capsules, suspensions,...
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
The essential consequences of polymorphism in the pharmaceutical field
Some regulatory aspects of the pharmaceutical sector
Article included in this offer
"Physics and chemistry"
(
203 articles
)
Updated and enriched with articles validated by our scientific committees
A set of exclusive tools to complement the resources
References
Exclusive to subscribers. 97% yet to be discovered!
Already subscribed? Log in!
